Development of streamlined chemoenzymatic glycan remodeling systems for antibodies and other important glycoproteins
Ended Project Grant Awarded Last action
- Award ID
- R43GM134816
- Recipient
-
Glycot Therapeutics LLC UEI Q9DESREWJJ39
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date
- Place of performance
- Maryland, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $150,000 | |
| Original award | $150,000 |
Quick answers
Who received award R43GM134816?
R43GM134816 was awarded to Glycot Therapeutics LLC by National Institute of General Medical Sciences (National Institutes of Health) on August 1, 2019.
How much is award R43GM134816 worth?
$300,000 has been obligated on R43GM134816.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award